Rehasaku Co., Ltd.

Based in Japan, Rehasaku Co. , Ltd. develops innovative rehabilitation solutions aimed at enhancing patient recovery and mobility through advanced therapeutic devices. Rehasaku Co.

, Ltd. is focused on creating rehabilitation solutions that enhance mobility and recovery. Founded in 2018 in Tokyo, Japan, the company has completed 3 deals, with its most recent funding round occurring on August 9, 2023. In this round, the firm raised JPY 150 million from investors including ANRI, DNX Ventures, and Welby Inc.

Rehasaku has raised a total of JPY 150 million to date. Rehasaku specializes in providing innovative rehabilitation solutions focused on enhancing patient recovery and mobility. Their core product offerings include advanced therapeutic devices designed to assist individuals with mobility impairments and physical disabilities. These devices incorporate technology to facilitate therapeutic applications, such as strengthening exercises, mobility training, and pain management.

The company's solutions target healthcare providers, rehabilitation centers, and clinics, serving a diverse client base that includes physical therapists, occupational therapists, and affected patients. Rehasaku's products are marketed in various regions, including North America, Europe, and select Asian markets. Rehasaku generates revenue through a B2B model, partnering with healthcare facilities and rehabilitation centers to distribute its flagship products. The transaction framework revolves around direct sales and long-term partnerships, allowing clinics to access the company's advanced therapeutic solutions.

Pricing plans accommodate the varying needs of healthcare providers, with options for bulk purchase agreements and leasing arrangements, ensuring accessibility while maintaining a steady revenue stream. The firm also engages in ongoing support and training for its clients, which enhances the value of its offerings and solidifies client relationships. In August 2023, Rehasaku Co. , Ltd.

raised JPY 150 million in venture funding from new investor Welby Inc. , with participation from ANRI and DNX Ventures. The funding will be utilized to collaborate on the utilization of Personal Health Records (PHR) in the rehabilitation field and expand services to the medical industry. The company aims to introduce new products designed for enhanced rehabilitation solutions and plans to target expansion into new markets, details of which have yet to be disclosed.